Skip to main content

RAPT Therapeutics, Inc.

RAPTDelisted Mar 3, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001673772

RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.

13F holders, Q4 2023

Institutional positions in RAPT Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
109
+14 vs. Q3 2023
Shares held
35.0M
+229.0K (+0.7%) vs. Q3 2023
Total value
$869.3M
+$291.7M (+50.5%) vs. Q3 2023
New holders
22
38 more added
Sold out
8
36 more reduced

1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RAPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2023: 109 institutions
Q1 2021: 78 institutionsQ2 2021: 109 institutionsQ3 2021: 106 institutionsQ4 2021: 99 institutionsQ1 2022: 85 institutionsQ2 2022: 85 institutionsQ3 2022: 98 institutionsQ4 2022: 95 institutionsQ1 2023: 106 institutionsQ2 2023: 98 institutionsQ3 2023: 96 institutionsQ4 2023: 109 institutionsQ1 2024: 122 institutionsQ2 2024: 103 institutionsQ3 2024: 94 institutionsQ4 2024: 91 institutionsQ1 2025: 92 institutionsQ2 2025: 50 institutionsQ3 2025: 65 institutionsQ4 2025: 106 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ4 2023: $869.3M
Q1 2021: $468.4MQ2 2021: $846.6MQ3 2021: $817.8MQ4 2021: $1.02BQ1 2022: $616.1MQ2 2022: $542.7MQ3 2022: $721.0MQ4 2022: $634.7MQ1 2023: $610.5MQ2 2023: $636.7MQ3 2023: $577.8MQ4 2023: $869.3MQ1 2024: $287.2MQ2 2024: $97.0MQ3 2024: $59.9MQ4 2024: $199.5MQ1 2025: $160.0MQ2 2025: $135.6MQ3 2025: $428.0MQ4 2025: $1.02BQ1 2026: $0Q2 2026: $0
Institutions holding RAPT and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 2025106$1.02B
Q3 202565$428.0M
Q2 202550$135.6M
Q1 202592$160.0M
Q4 202491$199.5M
Q3 202494$59.9M
Q2 2024103$97.0M
Q1 2024122$287.2M
Q4 2023109$869.3M
Q3 202396$577.8M
Q2 202398$636.7M
Q1 2023106$610.5M
Q4 202295$634.7M
Q3 202298$721.0M
Q2 202285$542.7M
Q1 202285$616.1M
Q4 202199$1.02B
Q3 2021106$817.8M
Q2 2021109$846.6M
Q1 202178$468.4M

Institutions, Q4 2023

Shares, value and share of portfolio for each institution holding RAPT Therapeutics, Inc.; share changes are against Q3 2023.

Institutions holding RAPT in Q4 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Great West Life Assurance Co1,159$29.0K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.791$19.6K0.00%+585+284.0%Added
Comerica Bank223$5.54K0.00%+23+11.5%Added
Daiwa Securities Group Inc.101$3.00K0.00%00.0%Unchanged
CWM, LLC22$1.00K0.00%+22New
GAMMA Investing LLC23$5690.00%+23New
US Bancorp11$2730.00%00.0%Unchanged
Nisa Investment Advisors, LLC9$2240.00%−15−62.5%Reduced
Farther Finance Advisors, LLC2$500.00%+2New
Boxer Capital, LLC0$00.00%−300,000−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−39,843−100.0%Sold out
Cheyne Capital Management (UK) LLP0$00.00%−20,000−100.0%Sold out
Allianz Asset Management GmbH0$00.00%−18,100−100.0%Sold out
Simplex Trading, LLC0$00.00%−669−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−581−100.0%Sold out
Signaturefd, LLC0$00.00%−33−100.0%Sold out
Allworth Financial LP0$00.00%−13−100.0%Sold out
Virginia Retirement Systems Et Al––––Not filed